The timing of a positive test result for heparin-induced thrombocytopenia relative to the platelet count and anticoagulant therapy in 43 consecutive cases

Majed A. Refaai, Elizabeth M. Van Cott, Michael Laposata

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

We studied the timing of a positive heparin-induced thrombocytopenia (HIT) test result relative to changes in platelet count and anticoagulant use. We obtained platelet counts in 100 consecutive HIT+ cases before, during, and after heparin therapy; 43 cases met study criteria and were included in study part 1. In part 2, platelet counts at the time of the HIT test in 2 groups (100 each HIT+ and HIT-cases) were compared. In part 1, cases could be divided into 4 groups based on the diagnosis of HIT relative to platelet counts (1, within 1-2 days of a major drop in platelet count [11.6%]; 2, after >2 days of a majorfall in platelet count [41.9%]; 3, in patients with already low platelet counts [27.9%]; 4, after platelet count was rising [18.6%]). In study part 2, the mean platelet counts for the HIT+ and HIT-groups were almost identical. HIT should be suspected in any thrombotic patient who had a previous decline in platelet count, has a low platelet count, or has a rising platelet count after a previous decline in association with heparin exposure. In study part 2, 1 platelet count value at the time of the HIT test did not provide useful information.

Original languageEnglish (US)
Pages (from-to)497-504
Number of pages8
JournalAmerican Journal of Clinical Pathology
Volume119
Issue number4
DOIs
StatePublished - Apr 1 2003
Externally publishedYes

Fingerprint

Platelet Count
Thrombocytopenia
Anticoagulants
Heparin
Therapeutics

Keywords

  • Heparin
  • Heparin-induced thrombocytopenia
  • Platelet count
  • Thrombocytopenia
  • Thrombosis

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Cite this

The timing of a positive test result for heparin-induced thrombocytopenia relative to the platelet count and anticoagulant therapy in 43 consecutive cases. / Refaai, Majed A.; Van Cott, Elizabeth M.; Laposata, Michael.

In: American Journal of Clinical Pathology, Vol. 119, No. 4, 01.04.2003, p. 497-504.

Research output: Contribution to journalArticle

@article{d7c5591990ec4f579b26321b2ae8d24f,
title = "The timing of a positive test result for heparin-induced thrombocytopenia relative to the platelet count and anticoagulant therapy in 43 consecutive cases",
abstract = "We studied the timing of a positive heparin-induced thrombocytopenia (HIT) test result relative to changes in platelet count and anticoagulant use. We obtained platelet counts in 100 consecutive HIT+ cases before, during, and after heparin therapy; 43 cases met study criteria and were included in study part 1. In part 2, platelet counts at the time of the HIT test in 2 groups (100 each HIT+ and HIT-cases) were compared. In part 1, cases could be divided into 4 groups based on the diagnosis of HIT relative to platelet counts (1, within 1-2 days of a major drop in platelet count [11.6{\%}]; 2, after >2 days of a majorfall in platelet count [41.9{\%}]; 3, in patients with already low platelet counts [27.9{\%}]; 4, after platelet count was rising [18.6{\%}]). In study part 2, the mean platelet counts for the HIT+ and HIT-groups were almost identical. HIT should be suspected in any thrombotic patient who had a previous decline in platelet count, has a low platelet count, or has a rising platelet count after a previous decline in association with heparin exposure. In study part 2, 1 platelet count value at the time of the HIT test did not provide useful information.",
keywords = "Heparin, Heparin-induced thrombocytopenia, Platelet count, Thrombocytopenia, Thrombosis",
author = "Refaai, {Majed A.} and {Van Cott}, {Elizabeth M.} and Michael Laposata",
year = "2003",
month = "4",
day = "1",
doi = "10.1309/KM2Y9H9TP6DA59MT",
language = "English (US)",
volume = "119",
pages = "497--504",
journal = "American Journal of Clinical Pathology",
issn = "0002-9173",
publisher = "American Society of Clinical Pathologists",
number = "4",

}

TY - JOUR

T1 - The timing of a positive test result for heparin-induced thrombocytopenia relative to the platelet count and anticoagulant therapy in 43 consecutive cases

AU - Refaai, Majed A.

AU - Van Cott, Elizabeth M.

AU - Laposata, Michael

PY - 2003/4/1

Y1 - 2003/4/1

N2 - We studied the timing of a positive heparin-induced thrombocytopenia (HIT) test result relative to changes in platelet count and anticoagulant use. We obtained platelet counts in 100 consecutive HIT+ cases before, during, and after heparin therapy; 43 cases met study criteria and were included in study part 1. In part 2, platelet counts at the time of the HIT test in 2 groups (100 each HIT+ and HIT-cases) were compared. In part 1, cases could be divided into 4 groups based on the diagnosis of HIT relative to platelet counts (1, within 1-2 days of a major drop in platelet count [11.6%]; 2, after >2 days of a majorfall in platelet count [41.9%]; 3, in patients with already low platelet counts [27.9%]; 4, after platelet count was rising [18.6%]). In study part 2, the mean platelet counts for the HIT+ and HIT-groups were almost identical. HIT should be suspected in any thrombotic patient who had a previous decline in platelet count, has a low platelet count, or has a rising platelet count after a previous decline in association with heparin exposure. In study part 2, 1 platelet count value at the time of the HIT test did not provide useful information.

AB - We studied the timing of a positive heparin-induced thrombocytopenia (HIT) test result relative to changes in platelet count and anticoagulant use. We obtained platelet counts in 100 consecutive HIT+ cases before, during, and after heparin therapy; 43 cases met study criteria and were included in study part 1. In part 2, platelet counts at the time of the HIT test in 2 groups (100 each HIT+ and HIT-cases) were compared. In part 1, cases could be divided into 4 groups based on the diagnosis of HIT relative to platelet counts (1, within 1-2 days of a major drop in platelet count [11.6%]; 2, after >2 days of a majorfall in platelet count [41.9%]; 3, in patients with already low platelet counts [27.9%]; 4, after platelet count was rising [18.6%]). In study part 2, the mean platelet counts for the HIT+ and HIT-groups were almost identical. HIT should be suspected in any thrombotic patient who had a previous decline in platelet count, has a low platelet count, or has a rising platelet count after a previous decline in association with heparin exposure. In study part 2, 1 platelet count value at the time of the HIT test did not provide useful information.

KW - Heparin

KW - Heparin-induced thrombocytopenia

KW - Platelet count

KW - Thrombocytopenia

KW - Thrombosis

UR - http://www.scopus.com/inward/record.url?scp=85047688014&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85047688014&partnerID=8YFLogxK

U2 - 10.1309/KM2Y9H9TP6DA59MT

DO - 10.1309/KM2Y9H9TP6DA59MT

M3 - Article

C2 - 12710122

AN - SCOPUS:85047688014

VL - 119

SP - 497

EP - 504

JO - American Journal of Clinical Pathology

JF - American Journal of Clinical Pathology

SN - 0002-9173

IS - 4

ER -